Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Mar-31-18 | Dec-31-17 | Sep-30-17 | Jun-30-17 | Mar-31-17 | Dec-31-16 | Sep-30-16 | Jun-30-16 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues |
| Impax Generics | 83.1 | 112.9 | 151.1 | 150.9 | 134.1 | 139.2 | 175.3 | 121.7 |
| Impax Specialty Pharma | 59.2 | 70.0 | 55.3 | 51.2 | 50.3 | 59.2 | 52.6 | 50.9 |
| |
| EBIT |
| Impax Generics | -113.7 | -215.6 | -21.5 | 12.6 | -38.8 | -212.1 | -233.3 | 18.5 |
| Impax Specialty Pharma | 20.9 | -54.0 | 16.4 | 6.9 | 11.2 | -17.4 | -6.7 | 13.1 |
| |
| Mix |
| Impax Generics | 58.4% | 61.7% | 73.2% | 74.7% | 72.7% | 70.2% | 76.9% | 70.5% |
| Impax Specialty Pharma | 41.6% | 38.3% | 26.8% | 25.3% | 27.3% | 29.8% | 23.1% | 29.5% |
| |
| Growth |
| Impax Generics | -38.0% | -18.9% | -13.8% | 24.0% | -21.1% | -38.6% | -3.0% | -30.3% |
| Impax Specialty Pharma | 17.8% | 18.2% | 5.1% | 0.6% | -9.3% | 7.1% | 30.1% | 28.8% |
|